Turin 23-24 September 2016 Italian and European experiences come across: IBD and beyond
Turin 23-24 September 2016 RATIONALE Le malattie infiammatorie croniche (IBD) non sono solo un problema clinico, ma anche epidemiologico e gestionale che trascende costantemente il campo della semplice Gastroenterologia, richiedendo spesso il coinvolgimento di diverse figure professionali per la gestione delle molteplici problematiche che interessano il paziente. Il meeting internazionale, giunto quest anno alla sua quarta edizione con cadenza biennale, mira ad approfondire molti di questi aspetti coinvolgendo esperti internazionali e platee di specialisti che si dedicano alla gestione di queste malattie in Italia e all estero. Le precedenti edizioni hanno consentito di sviluppare il confronto con il Belgio (2010), la Francia (2012), i Paesi dell Europa Orientale (2014). In questa edizione il confronto avverrà con i colleghi Danesi e Tedeschi. L organizzazione del meeting è volta a favorire, grazie alle numeriche limitate dei partecipanti (120 discenti al massimo), un contatto con i maggiori esperti nazionali e internazionali, anche allo scopo di favorire un attività di networking che possa durare al di fuori ed al di là dell evento stesso. Ci auguriamo di potervi trovare a Torino per il meeting! RATIONALE Inflammatory bowel diseases (IBDs) are not only a clinical issue, but also an epidemiological and management issue, which often overcomes the field of Gastroenterology itself. Different health care practicioners with specific profiles are needed to solve different and peculiar problems that patients are facing. This international meeting approaches this year its fourth biennial edition, and it is focused to clarify many of these issues through the involvement of international key opinion leaders and of Italian and international IBD expert physicians. Previous editions were based on the comparison between Italy and Belgium (2010), France (2012) and Easter European Countries (2014). This year the comparison will be with Danish and German colleagues. Based on the limited number of the attendees (120 partecipats maximum), the meeting is aimed to favour occasions of contact and networking with national and international key opinion leaders which may hopefully persist well after the meeting itself. We re looking forward to seeing you in Torino for the meeting! 2 3
Friday September 23 rd 2016 Turin 23-24 September 2016 First Session IBD Epidemiology: many answers and many open questions Chair: V. Annese 10.00-10.15 Welcome and meeting structure overview R. Rocca 10.15-10.35 IBD epidemiology in Italy: what we know and what we still have to explore A. Kohn 10.35-11.05 IBD epidemiology in Denmark: the Danish IBD registry and results on cancer, mortality and long-term treatment effects issues in IBD E. Langholz 11.05-11.25 Cancer and IBD, an Italian experience L. Biancone 11.25-11.45 How to build-up a solid epidemiologic study: the experience of ECCO-Epicom cohort N. Pedersen Second Session How deep should we assess IBD? Chair: F. Castiglione 14.00-14.20 The role of a common language in US: the IG-IBD Imaging project in Italy E. Calabrese 14.20-14.40 The role of a common language in endoscopy: the IG-IBD Endo project in Italy M. Comberlato 14.40-15.00 Beyond the scope: endomicroscopy and new endoscopic techniques G.E. Tontini 15.00-15.20 The role of Pathologists in IBD: diagnosis, activity and dysplasia V. Villanacci 15.20-15.40 What can you ask to MRI for inflammatory bowel disease? M. Petracchini 15.40-16.10 General Discussion 11.45-12.05 General discussion 16.10-16.40 Coffee Break EXTRA CME SESSION 12.05-12.35 LECTURE Efficacy and Safety of Adalimumab in Ulcerative Colitis G. Fiorino EXTRA CME SESSION 16.40-17.10 LECTURE Vedolizumab: bridging the future M. Daperno 12.35-14.00 Lunch break 4 5
Friday September 23 rd 2016 Saturday September 24 th, 2016 Turin 23-24 September 2016 Third Session Are we obtaining enough from traditional treatments? Chair: S. Ardizzone 17.10-17.30 Are all mesalamine the same? M. Vecchi 17.30-17.50 The use of ehealth to optimize mesalamine use N. Pedersen 17.50-18.10 Don t forget: why and when an Ophtalmologistist should kick in E. Miserocchi 18.10-18.30 Don t forget: why and when a Rheumatologist should kick in R. Pellerito 18.30-18.50 Don t forget: why and when a Dermatologist should kick in P. Dapavo 18.50-19.20 General discussion Fourth Session Escalating disease treatments: best strategies for clinical practice Chair: C. Papi 08.30-08.50 What is refractoriness? A user-guide for clinical practice A. Armuzzi 08.50-09.10 Patient profiling for biologic treatments P. Gionchetti 09.10-09.30 Real life experience with s.c. anti-tnf in Italy M. Daperno 09.30-09.50 Real life experience with vedolizumab in Germany D.C. Baumgart 09.50-10.10 Safety of biologics in the year 2016 A. Orlando 10.10-10.30 Danish data on long-term safety issues with anti-tnf agents I. Vind 10.30-10.50 Traditional treatments in the accelerated step-up paradigm in Germany: how use them U. Helwig 10.50-11.20 General discussion 11.20-11.50 Coffee break 6 7
Saturday September 24 th, 2016 Turin 23-24 September 2016 Fifth Session Fertility, pregnancy and miscellanea Chair: R. Rocca 11.50-12.10 Pregnancy and IBD: what do we know today? A. Bortoli 12.10-12.30 Fertility in IBD: what should our patients know? M. Julsgaard Nielsen 12.30-12.50 Is therapeutic drug monitoring becoming a real standard of practice in IBD? R. D Incà 12.50-13.10 IG-IBD registries results: an interim analysis on evolving projects F. Rizzello 13.10-13.50 General Discussion 13.50-14.00 CME testing 8 SCIENTIFIC & GENERAL INFORMATION
Turin 23-24 September 2016 PRESIDENT A.Pera SCIENTIFIC SECRETARY R. Rocca M. Daperno SCIENTIFIC COORDINATOR Daperno Marco, Turin (Italy) GENERAL INFORMATION VENUE NH Santo Stefano Via Porta Palatina, 19 10122 Torino LANGUAGE English is the official language of the Congress. FACULTY REGISTRATION Registration Fee 366,00 (VAT 22% included) Annese Vito, Florence (Italy) The Congress registration fee includes the final program, Ardizzone Sandro, Milan (Italy) the certificate of attendance, the admission to the scientific Armuzzi Alessandro, Rome (Italy) sessions, coffee breaks and lunches during breaks Baumgart Daniel, Berlin (Germany) Biancone Livia, Rome (Italy) CME- CONTINUING MEDICAL EDUCATION Bortoli Aurora, Milan (Italy) The Congress will be accredited with the CME Italian Calabrese Emma, Rome (Italy) system from the Provider PLS Educational for the Castiglione Fabiana, Naples (Italy) categories of Medical Professionals in Gastroenterology, Comberlato Michele, Bolzano (Italy) Pathological Anatomy, General Surgery and Internal Dapavo Paolo, Turin (Italy) Medicine D Incà Renata, Padoa (Italy) Fiorino Gionata, Milan (Italy) Gionchetti Paolo, Bologna (Italy) Helwing Ulf, Kiel (Germany) Julsgaard Nielsen Mette, Aarhus C (Denmark) Kohn Anna, Rome (Italy) Langholz Ebbe, Hellerup (Denmark) Miserocchi Elisabetta, Turin (Italy) Orlando Ambrogio, Palermo (Italy) Papi Claudio, Rome (Italy) Pedersen Natalia, Herlev (Denmark) Pellerito Raffaele, Turin (Italy) Petracchini Massimo, Turin (Italy) Rizzello Fernando, Bologna (Italy) Rocca Rodolfo, Turin (Italy) Tontini Gian Eugenio, Milan (Italy) Vecchi Maurizio, Milan (Italy) Villanacci Vincenzo, Brescia (Italy) 10 Vind Ida, Hvidovre (Denmark) 11
UNDER THE AEGIS OF THE SCIENTIFIC SECRETARY WANTS TO EXPRESS ITS HEARTFELT THANKS TO ALL THE SPONSORS FOR THEIR EDUCATIONAL AND NO-CONDITIONING CONTRIBUTION FOR THE CONGRESS REALIZATION CHIESI FARMACEUTICI ORGANIZING SECRETARY PLS Educational Florence, ITALY ibd-turin2016@promoleader.com www.maki-adv.it